Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Veeva Systems Inc.
Veeva sells cloud software and data that help life sciences companies develop, test, and sell medicines.
Veeva makes the software that runs a big chunk of the pharmaceutical world. Drug companies, biotech firms, and medical device makers use it to manage the messy, heavily regulated work of inventing a medicine and getting it approved — organizing clinical trial data, tracking safety complaints, and keeping the paperwork that regulators demand. If you picture a drug company as a giant machine with thousands of moving parts and inspectors watching every one, Veeva sells the control panel.
Its best-known product is Veeva CRM, customer relationship management software built on the Salesforce platform that sales reps use to plan visits to doctors and hospitals. But the bigger strategic bet is Veeva Vault, a suite of cloud applications that cover the whole life of a drug: clinical trials, regulatory filings, quality control, and manufacturing documentation. These are the systems a company cannot easily rip out once they are wired into its daily work, which is why customers tend to stay for a long time and keep buying more modules. The main source of money is subscriptions to these cloud products, and customers pay per user, mostly through multi-year contracts. Veeva also earns fees from services that help customers set up the software, and it sells data — things like prescriber and patient records — that sales teams use to target the right doctors. It even runs industry events where drug companies gather. Rivals exist to be sure — Salesforce powers its CRM, and IQVIA and other data providers compete on information — but Veeva's pitch is that it is purpose-built for one industry, so it understands the rules better than general-purpose software.
Veeva is based in the San Francisco Bay Area and was co-founded by Peter Gassner, a software veteran, and Matt Wallach, and it has grown into one of the more profitable software companies around, with steady double-digit revenue growth and piles of cash. It generally avoids big acquisitions, instead plowing money into building new products. One thing to watch: it once depended heavily on Salesforce's platform, and it has been migrating its CRM onto its own technology to gain independence. That shift is a quiet but important bet on controlling its own destiny.
Saved answer · last researched 12 Nov 2026